Sponsors (4)
The bill seeks better data to identify and address contraceptive access gaps at community health centers—potentially improving availability for women—while risking additional administrative burdens, unfunded compliance costs for clinics, and a study scope that could bias which methods receive attention.
Women in health-care deserts will gain clearer, data-driven identification of local gaps in availability of at least two contraceptive methods, enabling more targeted responses by policymakers and providers.
Policymakers and funders will be able to identify which community health centers receive Title X funding, allowing for more targeted allocation of resources and oversight to centers providing contraceptive services.
Analysis of reimbursement, stocking, training, and patient education could drive policy fixes that reduce barriers and increase contraceptive availability at community health centers, benefiting women who rely on these clinics.
Community health centers—especially small or resource-poor clinics—could face unfunded costs (training, stocking, administrative changes) if the study's findings lead to new requirements.
Definitions and scope choices in the study (e.g., inclusion of certain methods or exclusion of emergency contraception) could bias the inquiry and limit attention to some contraceptive options, narrowing benefits for women.
The study imposes additional administrative burden on HHS and community health centers to collect and report data, without guaranteeing follow-through or service changes.
Based on analysis of 2 sections of legislative text.
Requires HHS to study access to multiple contraceptive methods at community health centers in health care deserts and report findings to Congress within 180 days.
Introduced March 25, 2026 by Ashley Hinson · Last progress March 25, 2026
Requires the Department of Health and Human Services to study access by women in "health care deserts" to a range of contraceptive methods at community health centers and to report the results to Congress within 180 days of enactment. The study must examine reimbursement, inventory stocking, provider training, patient education, other barriers, and identify which centers receive Title X funding. The law only mandates a study and a congressional report; it does not create new programs, authorize spending, or change reimbursement rules. It also supplies definitions for key terms used in the study and sets the reporting deadline.